LD Micro - Announces Preliminary List of Presenters for the LD 500

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

NervGen Pharma Reports 2023 Year-End Financial Results and Operational Updates
NervGen Completes $23 Million Bought Deal Financing
NervGen Pharma Recognized as a Top 50 TSX Venture Exchange Company
NervGen Pharma Grants Stock Options
NervGen Pharma on Track to Complete Enrollment, Deliver Data Readout in Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury
NervGen Pharma Reports Q3 2023 Financial Results and Operational Updates
Neuroscientist and NervGen Pharma Scientific Founder, Dr. Jerry Silver, Interviewed on 'Remarkable People' Podcast Hosted by Tech Luminary Guy Kawasaki
NervGen Pharma Receives Fast Track Designation for NVG-291 for the Treatment of Individuals with Spinal Cord Injury

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.